Tag Archives: false advertising

claims about game provider’s bot use in “fair” and “skill-based” games must go to trial

Skillz Platform Inc. v. Papaya Gaming, Ltd., 2025 WL 3012836, 24cv1646(DLC) (S.D.N.Y. Oct. 27, 2025) Most recent previous opinion discussed here. Skillz sued its competitor in the “real-money skill-based mobile gaming” market for violating the Lanham Act and NY GBL … Continue reading →

Posted in Uncategorized | Tagged | Leave a comment

bad Lanham Act claim, swept up with bad patent claim, triggers Rule 11 sanctions

Raydiant Oximetry, Inc. v. ALC Medical Holdings LLC, — F.Supp.3d —-, 2025 WL 3022882, No. 25-cv-00392-VC (N.D. Cal. Oct. 29, 2025) Baseless patent and false advertising claims produce a big Rule 11 award. The patent stuff is eye-popping, and it’s … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

allegedly false claims for compounded weight loss drugs didn’t plausibly threaten Eli Lilly’s reputation

Eli Lilly & Co. v. Mochi Health Corp., 2025 WL 2998166, No. 25-cv-03534-JSC (N.D. Cal. Oct. 24, 2025) Another of the cases in which Eli Lilly’s attempts to protect its GLP-antagonist market do surprisingly badly, once again highlighting the higher … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

Coinbase can’t force claim for injunctive relief into arbitration

Khan v. Coinbase, Inc., 2025 WL 2985378, No. A172063, — Cal.Rptr.3d —-, (Ct. App. Oct. 23, 2025) The appellate court affirmed the denial of Coinbase’s attempt to send Khan’s false advertising claims to arbitration, holding that Khan sought public injunctive … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

“GMO-free” avocado oil isn’t deceptive even if all avocado oil is GMO-free

Whiteside v. Chosen Foods, LLC, — F.Supp.3d —-, 2025 WL 2460192, No. 3:25-cv-00481-CAB-DDL (S.D. Cal. Aug. 26, 2025) xkcd, “Free” XKCD may hate it, but the law will allow it. Plaintiff alleged that defendants misleadingly advertised their avocado oil by … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

Another “natural” claim proceeds for pet food labeled “natural + vitamins, minerals, and other nutrients”

Cobovic v. Mars Petcare US, Inc., — F.Supp.3d —-, No. 24-CV-7730 (ARR) (JAM) (E.D.N.Y. Jun. 20, 2025) Cobovic alleged that the use of the word “natural” on the front label pet food was false and misleading under NY law because … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

claims about scientific studies might imply FDA approval

BioGaia USA, LLC v. Probiotiv Naturals LLC, 2025 WL 2946910, No. CV 25-3592 PA (MBKx) (C.D. Cal. Sept. 5, 2025) BioGaia sued Probiotiv – a competitor in the sale of priobiotic dietary supplements for oral health, for false advertising; Probiotiv … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

New Jersey would not recognize a common law tort of false advertising, says fed ct

Pim Brands, Inc. v. New Cibo Vita LLC, No. 25-cv-01418(MEF)(AME), 2025 WL 2938602 (D.N.J. Oct. 16, 2025) The parties compete in the market for yogurt-covered fruit snacks, and the plaintiff alleged false advertising, including unfair competition claim under New Jersey … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

California’s limits on use of “doctor” in healthcare settings are constitutional regulations of commercial speech

Palmer v. Bonta, 2025 WL 2882948, No. EDCV 23-1047 JGB (SPx) (C.D. Cal. Sept. 19, 2025) Plaintiffs alleged that California Business and Professions Code § 2054(a), on its face and as enforced, violates the First Amendment because it provides, in … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

court allows false advertising claim based on manipulation of Amazon’s “variation” system

Corsair Gaming, Inc. v. Choice Electronics Inc., 2025 WL 2822691, No. 5:25-cv-00045-BLF (N.D. Cal. Oct. 3, 2025) Corsair sued Choice for alleged infringement by selling used, unauthorized, or counterfeit Corsair computer/gaming products. This opinion deals with Choice’s counterclaims. The false … Continue reading →

Posted in Uncategorized | Tagged | Leave a comment